| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 751 | 10.989 | 15.042 | 10.958 | 10.935 | 19.311 | 29.993 | 40.199 | 44.506 | 76.086 |
| Total Income - EUR | 761 | 10.999 | 39.005 | 31.480 | 10.935 | 39.459 | 45.384 | 47.715 | 38.787 | 134.452 |
| Total Expenses - EUR | 28.134 | 24.398 | 23.794 | 25.402 | 22.803 | 29.157 | 42.468 | 35.776 | 35.387 | 97.309 |
| Gross Profit/Loss - EUR | -27.373 | -13.399 | 15.212 | 6.078 | -11.868 | 10.302 | 2.916 | 11.939 | 3.399 | 37.143 |
| Net Profit/Loss - EUR | -27.396 | -13.495 | 15.061 | 5.920 | -11.977 | 10.114 | 2.462 | 11.537 | 2.954 | 35.906 |
| Employees | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Acva Mc Nasal Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.020 | 2.175 | 8.179 | 14.320 | 19.077 | 33.420 | 43.662 | 43.494 | 63.013 | 58.548 |
| Current Assets | 20.203 | 18.401 | 41.271 | 62.140 | 60.886 | 84.945 | 83.641 | 93.559 | 85.856 | 127.846 |
| Inventories | 16.127 | 16.656 | 40.877 | 61.693 | 60.498 | 81.533 | 82.631 | 92.677 | 76.516 | 116.706 |
| Receivables | 3.525 | 1.729 | 243 | 759 | 715 | 3.150 | 889 | 363 | 691 | 350 |
| Cash | 551 | 15 | 151 | -313 | -328 | 262 | 121 | 519 | 8.649 | 10.789 |
| Shareholders Funds | -27.230 | -40.447 | -24.702 | -18.328 | -29.951 | 11.473 | 13.681 | 25.076 | 27.954 | 63.703 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 48.453 | 61.024 | 74.152 | 94.787 | 109.914 | 106.892 | 113.623 | 111.978 | 120.915 | 122.690 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "322 - 322" | |||||||||
| CAEN Financial Year |
322
|
|||||||||
Comments - Acva Mc Nasal Srl